Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Buildings (2016 - 2025)

Pediatrix Medical (MD) has disclosed Buildings for 16 consecutive years, with $8.3 million as the latest value for Q4 2025.

  • Quarterly Buildings changed 0.0% to $8.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.3 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $8.3 million for FY2025, 0.0% changed from the prior year.
  • Buildings for Q4 2025 was $8.3 million at Pediatrix Medical, roughly flat from $8.3 million in the prior quarter.
  • The five-year high for Buildings was $8.3 million in Q4 2021, with the low at $8.3 million in Q4 2021.
  • Average Buildings over 5 years is $8.3 million, with a median of $8.3 million recorded in 2021.
  • The sharpest move saw Buildings plummeted 69.24% in 2021, then changed 0.0% in 2022.
  • Over 5 years, Buildings stood at $8.3 million in 2021, then changed by 0.0% to $8.3 million in 2022, then changed by 0.0% to $8.3 million in 2023, then changed by 0.0% to $8.3 million in 2024, then changed by 0.0% to $8.3 million in 2025.
  • According to Business Quant data, Buildings over the past three periods came in at $8.3 million, $8.3 million, and $8.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.